RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
 Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Research Article
Latest Research Channel

subscribe to Latest Research newsletter
Latest Research

   EMAIL   |   PRINT
Monthly shot for holiday drinkers on wagon

Dec 17, 2008 - 5:00:00 AM
The results have impressed Rosenbloom, who describes their significance for public health as huge. Lapham warns that naltrexone injections must be given with care, because they can cause abscesses if the drug is deposited into fatty tissue.

 
[RxPG] ALCOHOLICS struggling to keep off shots of the hard stuff over the festive season may want to consider an alternative shot: a monthly injection that keeps them off the booze.

For people battling alcoholism, holidays pose a strong danger of relapse. When you interview patients about triggers for drinking, they often say holidays and family events, says David Rosenbloom, a specialist in substance abuse at Boston University School of Public Health. For some it's the stress of being lonely, for others it's the stress of being with people. Over Christmas and New Year, social pressure and opportunities to drink add to the intoxicating mix.

Some people take pills containing naltrexone, a substance that reduces the desire to drink by blocking the receptors in the brain responsible for the high that drinking brings. But during the holiday season, pressures often drive alcoholics to stop taking the tablets. With a pill, they have to make a decision every day, says Sandra Lapham at the Behavioral Health Research Center of the Southwest in Albuquerque, New Mexico.

In 2006, the US Food and Drug Administration approved a slow-release formulation of naltrexone, in which the drug is stored in microscopic spheres made of a biodegradable polymer and injected into muscle once a month. Lapham wondered if this might help people who stop taking naltrexone pills during holidays. Working with the company that manufactures the formulation - Alkermes, based in Cambridge, Massachusetts - she reanalysed data from a previous clinical trial, focusing on the drug's performance during 10 US holidays and celebrations.

The study was small - just 28 patients received full-dose naltrexone shots, compared with another 28 given placebos. The shots reduced the frequency of drinking days, the number of drinks and the percentage of days classed as heavy drinking sessions - five or more drinks a day for men, and four for women. Crucially, the drug was just as effective during the holidays as it was for the rest of the year (Journal of Substance Abuse Treatment, vol 36, p 1).

The results have impressed Rosenbloom, who describes their significance for public health as huge. Lapham warns that naltrexone injections must be given with care, because they can cause abscesses if the drug is deposited into fatty tissue.

The treatment might also reduce deaths from drink-driving: in the US, 40 per cent of road deaths over Christmas and the New Year involve at least one driver impaired by alcohol, compared with about 28 per cent for the rest of December. Rosenbloom would like to see courts offer naltrexone shots to repeat drink-driving offenders.




Advertise in this space for $10 per month. Contact us today.


Related Latest Research News


Subscribe to Latest Research Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)